Stephanie Lovell, Director at TransMedics Group, Inc. (TMDX), sold 1,193 shares at $149.62 ($178K) on 2026-03-04, disclosed to the SEC on 2026-03-06.
Open-market sale of $178k TMDX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.